Episode 118: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life episode artwork

EPISODE · Jul 2, 2020 · 22 MIN

Episode 118: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life

from The Readout Loud · host STAT

What’s a fair price for remdesivir? How do we know whether vaccines work? And does AI have a place in end-of-life care?

Episode metadata supplied by the publisher feed · Published Jul 2, 2020

Embed this episode

Ready to play

Episode 118: Remdesivir’s controversial cost, early vaccine promise, and AI at the end of life

0:00 22:25

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 22 minutes long.

When was this The Readout Loud episode published?

This episode was published on July 2, 2020.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!